Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-26-060391
Filing Date
2026-05-13
Accepted
2026-05-13 17:28:27
Documents
19

Document Format Files

Seq Description Document Type Size
1 S-3 tm2614252-1_s3.htm S-3 666904
2 EXHIBIT 4.3 tm2614252d2_ex4-3.htm EX-4.3 458792
3 EXHIBIT 4.5 tm2614252d2_ex4-5.htm EX-4.5 113757
4 EXHIBIT 4.6 tm2614252d2_ex4-6.htm EX-4.6 112694
5 EXHIBIT 4.7 tm2614252d2_ex4-7.htm EX-4.7 101518
6 EXHIBIT 5.1 tm2614252d2_ex5-1.htm EX-5.1 29543
7 EXHIBIT 23.1 tm2614252d2_ex23-1.htm EX-23.1 2692
8 EX-FILING FEES tm2614252d1_ex-filingfees.htm   iXBRL EX-FILING FEES 34429
9 GRAPHIC tm2614252d2_ex5-1img001.jpg GRAPHIC 7036
10 GRAPHIC lg_milestonepharma-4c.jpg GRAPHIC 15063
  Complete submission text file 0001104659-26-060391.txt   1687751

Data Files

Seq Description Document Type Size
22 EXTRACTED XBRL INSTANCE DOCUMENT tm2614252d1_ex-filingfees_htm.xml XML 9547
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-295860 | Film No.: 26974743
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)